IEL Intrinsic Value
IEL (INDXTRA) median intrinsic value is ₹4.62 from 8 valuation models (range ₹2–₹14), vs current price ₹5.64 — -18.1% downside (Trading Above Median Value), margin of safety -22.1%. Also explore IEL stock price data download to track price trends across different timeframes.
INDXTRA Valuation Methods Summary — DCF, Graham Number & P/E
IEL intrinsic value across 8 models vs current price ₹5.64 — upside/downside and value range per method. Browse INDXTRA balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1.69 | ₹1.35 - ₹2.03 | -70.0% | EPS: ₹0.03, Sector P/E: 12x |
| Book Value Method | asset | ₹14.10 | ₹12.69 - ₹15.51 | +150.0% | Book Value/Share: ₹34.62, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹3.69 | ₹3.32 - ₹4.06 | -34.6% | Revenue/Share: ₹4.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹4.62 | ₹4.16 - ₹5.08 | -18.1% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹14.10 | ₹11.28 - ₹16.92 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.69 | ₹1.52 - ₹1.86 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.69 | ₹1.52 - ₹1.86 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹4.83 | ₹4.35 - ₹5.31 | -14.4% | EPS: ₹0.03, BVPS: ₹34.62 |
INDXTRA Intrinsic Value vs Market Price — All Valuation Models
IEL fair value range ₹2–₹14 vs current market price ₹5.64 across 8 valuation models. For current market price and key ratios, visit INDXTRA share price screener.
INDXTRA Intrinsic Value Analysis — Undervalued or Overvalued?
IEL median intrinsic value ₹4.62, current price ₹5.64 — Trading Above Median Value by 18.1%, margin of safety -22.1%.
What is the intrinsic value of INDXTRA?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of IEL (INDXTRA) is ₹4.62 (median value). With the current market price of ₹5.64, this represents a -18.1% variance from our estimated fair value.
The valuation range spans from ₹1.69 to ₹14.10, indicating ₹1.69 - ₹14.10.
Is INDXTRA undervalued or overvalued?
Based on our multi-method analysis, IEL (INDXTRA) appears to be trading above median value by approximately 18.1%.
INDXTRA Financial Health — Key Ratios vs Industry Benchmarks
IEL financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 47.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 10.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.13x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
INDXTRA Cash Flow Quality — Operating & Free Cash Flow
IEL operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹-9 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |